Detalhe da pesquisa
1.
A Phase I Dose-Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low-Grade or Intermediate-Grade B-Cell or T-Cell Lymphoma.
Oncologist
; 23(4): 397-e30, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438091